Please activate JavaScript!
Please install Adobe Flash Player, click here for download
ePaper created 2017-10-06, 11:25:59 | version 1.38.0
business Optimised implant treatment with new products from Osstell user of such instruments. This new platform provides relevant insights for practitioners to enhance their implant treatment performance. Furthermore, it allows clinicians to oversee and document implant treatments, track and predict heal- ing times, choose surgical and load- ing protocols more efficiently, share data, compare a clinic’s results with data averages from other Osstell- Connect users all over the world, back up data and obtain remote sup- port. Also to be showcased at the meeting is a new upcoming product designed to make measurements even easier, combining the Smart- Peg and the SmartPeg mount with a new design. This new solution has been developed in response to the feedback Osstell has received from clinicians, namely that the Smart- Peg mount is easily lost, making it difficult to attach the SmartPeg to perform the measurement, and that it is difficult to determine whether the SmartPeg is properly attached to the implant. This new product ad- dresses these two issues. Dental professionals can obtain more information at Booth S5. (cid:26) AD (cid:132) Patient-focused implant dentistry is changing and immediate loading protocols are being redefined to uti- lise the benefits of digital planning and the available diagnostic tools. That is why there is a need for an objective tool to guide and optimise implant treatment processes that is valid for both complex and simple cases. Swedish company Osstell—a global leader in implant stability measurement and osseointegration progress monitoring—yesterday pre- sented such new tools to clinicians to Geistlich Fibro-Gide® The alternative to connective tissue grafts Come to discover our new product at the Geistlich Booth Geistlich’s Collagen Expertise The first volume- stable collagen matrix designed for gaining soft-tissue thickness.1,2 1 European Patent Specification – EP 3 011 000 B1. (cid:6) Data on file. Geistlich Pharma AG, Wolhusen, Switzerland. (cid:24)Clinical presentation by Dr Giorgio Tabanella at the Osstell Symposium on Thursday. (© DTI) enhance their practices and support their work with high-quality prod- ucts. During an industry symposium held on Thursday morning here at the 2017 EAO-SEPES joint meeting, prominent clinicians, including Drs Steven Eckert (US), Luis Cuadrado (Spain), Giorgio Tabanella (Italy) and Marcus Dagnelid (Sweden), spoke on the most efficient practices in im- plant dentistry’s rapidly evolving protocols and workflows. Osstell’s proprietary and pat- ented technology is unique in terms of using resonance frequency analy- sis and ISQ (Implant Stability Quo- tient) technology to measure im- plant stability. It helps dentists around the world to make dental im- plant treatments even safer and to increase patient confidence and comfort through measuring the sta- bility of implants accurately and non-invasively using the ISQ scale. More than 860 scientific publica- tions have confirmed the benefits of the technology, its clinical value and the use of the ISQ scale for den- tists in their daily practices. Being validated and compatible with all leading implant systems, ISQ has be- come an international benchmark among dental implant specialists. OsstellConnect is an exclusive online service for Osstell IDx and other authorised and connected ISQ units and can be accessed by any www.geistlich-biomaterials.com 26th EAO Annual Scientific Meeting 21